Children's Hospital of Fudan University
Shanghai, Shanghai Municipality, 201102, China
NCT Number: NCT04143204
This study aims to explore the relation of early nutritional intake, especially oral nutrition intake, with growth and body composition among very preterm or very low birth weight infants.
Looking for future studies?
Notify Me1 day–18 month
All sexes
Observational
Shanghai, Shanghai Municipality, 201102, China
As the survival of very preterm infants increases, it is important to evaluate their long-term outcomes. Nutritional intake during early life was important to the growth and development in infants, especially in preterm infants. Studies found that early nutrition exposure in preterm infants can effect scored of Griffith Mental Development Scales and body fat percentage at later life. Insulin-like growth factor-1, leptin, Ghrelin, C-Peptide are associated with fat mass in children. And accumulation of fat and insulin resistance (IR) in the early postnatal period are related to metabolism diseases in adulthood. However, previous studies on nutrition and growth or the body composition of preterm infants were mostly completed in developed countries, and no relevant data were available in China. Therefore, this study aims to establish a prospective cohort of very preterm infants to observe the effects of nutritional exposure in early life on growth and body composition in later life.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The exposure are oral nutritional intake and all nutritional intake during early life (28 days), and insulin-like growth factor 1, leptin, Ghrelin, and C-peptide in serum at corrected age 40 gestational weeks.
Other names: All nutritional intake, Insulin-like growth factor 1, Leptin, Ghrelin, C-peptide
Time frame: at corrected age 40 gestational weeks
Computed according to the Fenton preterm growth standards (2013)
Time frame: at corrected age 40 gestational weeks
Computed according to the Fenton preterm growth standards (2013)
Time frame: at corrected age 40 gestational weeks
Computed according to the Fenton preterm growth standards (2013)
Time frame: at corrected age 6 months and 18 months
Computed according to the WHO standards (2006)
Time frame: at corrected age 6 months and 18 months
Computed according to the WHO standards (2006)
Time frame: at corrected age 6 months and 18 months
Computed according to the WHO standards (2006)
Time frame: at corrected age 6 months and 18 months
Catch-up growth is defined as weight, length/height or head circumference equal to or above the 25th percentile for corrected age, according to the WHO standards (2006).
Time frame: at corrected age 40 gestational weeks and 6 months
assessed by air displacement plethysmography (ADP)
Time frame: at corrected age 40 gestational weeks and 6 months
assessed by air displacement plethysmography (ADP)
Time frame: at corrected age 40 gestational weeks and 6 months
assessed by air displacement plethysmography (ADP)
Time frame: at corrected age 18 months
It is examined by six areas of development measured by Griffith Mental Development Scales (GMDS) including locomotor, personal-social, hearing and language, eye and hand co-ordination, performance and practical reasoning. Developmental impairment is defined as a developmental quotient lying one standard deviation below the mean (<85) and includes mild impairments (70-84) and moderate/severe impairment (<70).
Time frame: from birth to corrected age 18 months
The change of composition of intestinal flora in preterm infants. The composition of intestinal flora was test by 16s rRNA sequencing.
Children's Hospital of Fudan University
Other
Early Nutritional Intake and Growth in Very Preterm or Very Low Birth Weight Infants: a Prospective Cohort Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04067973
Female Urogenital Diseases and Pregnancy Complications, Obstetric Labor Complications
Nantes, France
View Trial DetailsNCT04432636
Female Urogenital Diseases and Pregnancy Complications, Obstetric Labor Complications
Rennes, France
View Trial DetailsNCT07371845
Behavior, Breast Feeding
Erzurum, Turkey (Türkiye)
View Trial DetailsNCT07266246
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases and Pregnancy Complications
Ankara, Turkey (Türkiye)
View Trial Details